Diagnosing and Assessing Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Douglas DiRuggiero, PA-C
Virtual (Zoom)
Learn more about the diagnosis and assessment of chronic spontaneous urticaria (CSU), including its clinical manifestations, diagnostic evaluation, assessment scales, and a treatment option for appropriate CSU patients 12+ years of age.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Ben Ehst, MD
Virtual (Zoom)
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
The Many Faces of Type 2 Inflammation: Unraveling Its Role Across Dermatologic Conditions and a Treatment Option for Appropriate Patients
by Meagen McCusker, MD
Virtual (Zoom)
Learn more about how Type 2 inflammation contributes to the clinical manifestations of atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU); which cytokines play key roles in driving this activity; and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
by Eingun Song, MD
Virtual (Zoom)
Learn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations and a treatment option for appropriate BP patients.
Beneath the Itch: The Role of Type 2 Inflammation and a Treatment Option for Appropriate Patients with Skin Diseases Driven in Part by Type 2 Inflammation
by Cory Rubin, MD
Virtual (Zoom)
Learn more about itch in patients with atopic dermatitis (AD), prurigo nodularis (PN), and chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate patients with certain skin diseases driven in part by Type 2 inflammation.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Jason Hawkes, MD
Virtual (Zoom)
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Alexandra Golant, MD
Virtual (Zoom)
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.
Exploring the Pathophysiology of Type 2 Inflammation in Chronic Spontaneous Urticaria (CSU) and a Treatment Option for Appropriate CSU Patients 12+ Years of Age
by Michael Payette, MD
Virtual (Zoom)
Learn more about the evolving understanding of the pathophysiology of chronic spontaneous urticaria (CSU) and a treatment option that may help appropriate CSU patients 12+ years of age.
Pearls and Common Challenges for the Diagnosis of Bullous Pemphigoid (BP)
by Raj Chovatiya, MD
Virtual (Zoom)
Learn more about the diagnosis and assessment of bullous pemphigoid (BP) including clinical manifestations, key laboratory investigations for diagnostic evaluation, consensus-based recommendations and a treatment option for appropriate BP patients.
Pathophysiology of Atopic Dermatitis and a Treatment Option for Appropriate Patients 6+ Months of Age With Uncontrolled Moderate-to-Severe Atopic Dermatitis
by Leigh Ann Pansch, NP
Virtual (Zoom)
Learn more about the pathophysiology of atopic dermatitis (AD) and a treatment option that may help appropriate patients with uncontrolled moderate-to-severe atopic dermatitis.